Zhao Jie-Feng, Zou Fei-Long, Zhu Jin-Feng, Huang Chao, Bu Fan-Qin, Zhu Zheng-Ming, Yuan Rong-Fa
Department of General Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.
Front Pharmacol. 2022 Oct 18;13:1025618. doi: 10.3389/fphar.2022.1025618. eCollection 2022.
Nano drug delivery system (NDDS) can significantly improve the delivery and efficacy of drugs against pancreatic cancer (PC) in many ways. The purpose of this study is to explore the related research fields of NDDS for PC from the perspective of bibliometrics. Articles and reviews on NDDS for PC published between 2003 and 2022 were obtained from the Web of Science Core Collection. CiteSpace, VOSviewer, R-bibliometrix, and Microsoft Excel were comprehensively used for bibliometric and visual analysis. A total of 1329 papers on NDDS for PC were included. The number of papers showed an upward trend over the past 20 years. The United States contributed the most papers, followed by China, and India. Also, the United States had the highest number of total citations and H-index. The institution with the most papers was Chinese Acad Sci, which was also the most important in international institutional cooperation. Professors Couvreur P and Kazuoka K made great achievements in this field. published the most papers and was cited the most. The topics related to the tumor microenvironment such as "tumor microenvironment", "tumor penetration", "hypoxia", "exosome", and "autophagy", PC treatment-related topics such as "immunotherapy", "combination therapy", "alternating magnetic field/magnetic hyperthermia", and "ultrasound", and gene therapy dominated by "siRNA" and "miRNA" were the research hotspots in the field of NDDS for PC. This study systematically uncovered a holistic picture of the performance of NDDS for PC-related literature over the past 20 years. We provided scholars to understand key information in this field with the perspective of bibliometrics, which we believe may greatly facilitate future research in this field.
纳米药物递送系统(NDDS)可以在许多方面显著提高抗胰腺癌(PC)药物的递送效率和疗效。本研究的目的是从文献计量学的角度探索用于胰腺癌的纳米药物递送系统的相关研究领域。从科学网核心合集中获取了2003年至2022年间发表的关于用于胰腺癌的纳米药物递送系统的文章和综述。综合使用CiteSpace、VOSviewer、R-bibliometrix和Microsoft Excel进行文献计量和可视化分析。共纳入1329篇关于用于胰腺癌的纳米药物递送系统的论文。在过去20年中,论文数量呈上升趋势。美国发表的论文最多,其次是中国和印度。此外,美国的总被引次数和H指数最高。发表论文最多的机构是中国科学院,它在国际机构合作中也最为重要。库夫勒尔·P教授和卡佐卡·K教授在该领域取得了巨大成就,发表的论文最多且被引次数最多。与肿瘤微环境相关的主题,如“肿瘤微环境”“肿瘤穿透”“缺氧”“外泌体”和“自噬”,与胰腺癌治疗相关的主题,如“免疫疗法”“联合疗法”“交变磁场/磁热疗”和“超声”,以及以“siRNA”和“miRNA”为主的基因疗法,是用于胰腺癌的纳米药物递送系统领域的研究热点。本研究系统地揭示了过去20年中用于胰腺癌的纳米药物递送系统相关文献的整体表现情况。我们从文献计量学的角度为学者们提供了该领域的关键信息,我们相信这可能会极大地促进该领域未来的研究。